.Income Statement Quarterly Data
Difficulty: Beginner
The income statement presents information on the financial results of a company's business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.
Bristol-Myers Squibb Co., Consolidated Income Statement (quarterly data)
USD $ in millions
| 3 months ended | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| | Net product sales | ||||||||||||||||||||||||||||||||||||||||||
| | Alliance and other revenues | ||||||||||||||||||||||||||||||||||||||||||
| | Revenues | | | | | | | | | | | | | | | | | | | | | | |||||||||||||||||||||
| | Cost of products sold | ||||||||||||||||||||||||||||||||||||||||||
| | Gross margin | | | | | | | | | | | | | | | | | | | | | | |||||||||||||||||||||
| | Marketing, selling and administrative | ||||||||||||||||||||||||||||||||||||||||||
| | Research and development | ||||||||||||||||||||||||||||||||||||||||||
| | Operating income | | | | | | | | | | | | | | | | | | | | | | |||||||||||||||||||||
| | Other income (expense), net | ||||||||||||||||||||||||||||||||||||||||||
| | Earnings before income taxes | | | | | | | | | | | | | | | | | | | | | | |||||||||||||||||||||
| | Provision for income taxes | ||||||||||||||||||||||||||||||||||||||||||
| | Net earnings (loss) | | | | | | | | | | | | | | | | | | | | | | |||||||||||||||||||||
| | Noncontrolling interest | ||||||||||||||||||||||||||||||||||||||||||
| | Net earnings (loss) attributable to BMS | | | | | | | | | | | | | | | | | | | | | |
| Item | Description | The company |
|---|---|---|
| Revenues | Aggregate revenue recognized during the period (derived from goods sold, services rendered, insurance premiums, or other activities that constitute an entity's earning process). For financial services companies, also includes investment and interest income, and sales and trading gains. | Bristol-Myers Squibb Co.'s revenues increased from Q3 2017 to Q4 2017 but then declined significantly from Q4 2017 to Q1 2018. |
| Operating income | The net result for the period of deducting operating expenses from operating revenues. | Bristol-Myers Squibb Co.'s operating income declined from Q3 2017 to Q4 2017 but then increased from Q4 2017 to Q1 2018 exceeding Q3 2017 level. |
| Earnings before income taxes | Sum of operating profit and nonoperating income (expense) before income (loss) from equity method investments, income taxes, extraordinary items, cumulative effects of changes in accounting principles, and noncontrolling interest. | Bristol-Myers Squibb Co.'s earnings before income taxes declined from Q3 2017 to Q4 2017 but then increased from Q4 2017 to Q1 2018 exceeding Q3 2017 level. |
| Net earnings (loss) | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. | Bristol-Myers Squibb Co.'s net earnings (loss) declined from Q3 2017 to Q4 2017 but then increased from Q4 2017 to Q1 2018 exceeding Q3 2017 level. |
| Net earnings (loss) attributable to BMS | The portion of consolidated profit or loss for the period, net of income taxes, which is attributable to the parent. If the entity does not present consolidated financial statements, the amount of profit or loss for the period, net of income taxes. | Bristol-Myers Squibb Co.'s net earnings (loss) attributable to BMS declined from Q3 2017 to Q4 2017 but then increased from Q4 2017 to Q1 2018 exceeding Q3 2017 level. |
